Hypertension among adults exposed to drinking water arsenic in Northern Chile
TB-500 Dosing Math by Vial Size 5 mg vial + 1 mL bacteriostatic water = 5 mg/mL (5,000 mcg/mL) 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL (2,500 mcg/mL) 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL (5,000 mcg/mL) The 5 mg/mL ratio (1 mL of water per 5 mg vial) is the most popular setup because the doses land on clean, easy numbers

TIER 0 (20mg total) $205 total for 10 week supply Monthly cost breakdown: $82 Recommended if using low (or micro) doses of 2mg/week or less TIER 1 (40mg total) $240 total for 8-10 week supply Monthly cost breakdown: $96-$120 based on weekly dose Recommended if new to treatment or for those on 2-5mg/week TIER 2 (60mg total) $270 total for 8-10 week supply Monthly cost breakdown: $108-$135 based on weekly dose Recommended for those on 6-7mg/week TIER 3 (80mg total) $300 total for 8-10 week supply Monthly cost breakdown: $120-$150 based on weekly dose Recommended for those on 8-10mg/week TIER 4 (120mg total) $325 total for 8-10 week supply Monthly cost breakdown: $130-$162 based on weekly dose Recommended for those on 11mg/week and up MONTHLY PLANS Monthly Starter Dose $149 total for one month supply Recommended if new to treatment or for those on doses of 2.5mg/week or less Monthly Mid Dose $169 total for one month supply Recommended for doses up to 7.5mg/week Monthly Advanced Dose $189 total for one month supply Recommended for doses of 7.5-10mg/week Monthly Advanced Plus Dose $199 total for one month supply Recommended for doses of 11mg/week and up Vios Pharmacy - Tirzepatide/Levocarnitine Injection (NEW) Up to 90 days BUD

The abdomen (at least 2 inches from the navel), outer thigh, and back of the upper arm are all suitable locations
In some embodiments, the needle gauge is about 18 gauge, about 19 gauge, about 20 gauge, about 21 gauge, about 22 gauge, about 23 gauge, about 24 gauge, about 25 gauge, about 26 gauge, about 27 gauge, about 28 gauge, about 29 gauge, or about 30 gauge
Mazdutide and tirzepatide both target weight loss as a primary outcome, addressing the global obesity epidemic impacting 1 in 8 people